Background: Approximately 20% to 50% of patients are not adherent to medical therapy. This review was performed to summarize, categorize, and estimate the effect size (ES) of interventions to improve medication adherence in chronic medical conditions.
Conclusion: Several types of interventions are effective in improving medication adherence in chronic medical conditions, but few significantly affected clinical outcomes. Med. 2007; 167:540-550 A N ESTIMATED 20% TO 50% of patients do not take their medications as prescribed and are said to be nonadherent or noncompliant with therapy. [1] [2] [3] In the setting of chronic medical conditions such as hypertension and hypercholesterolemia, medication nonadherence leads to worse medical treatment outcomes, higher hospitalization rates, and increased health care costs. 4, 5 Because of this, adherence has been called "the key mediator between medical practice and patient outcomes." 6 Researchers have tested a variety of interventions to improve patient adherence, ranging from simple adjustments in the medication regimen to complex multidisciplinary interventions that address health system barriers and communication between patients and health care professionals. [7] [8] [9] [10] However, the overall quality of the literature is poor, with wide variability in study design, including patient population, outcome measure, and duration of follow-up. 11 It is desirable to draw recommendations from a smaller set of high-quality studies.
Arch Intern
In a recent review for the Cochrane Database, 12 several simple interventions appeared to improve adherence with shortterm regimens, such as a course of antibiotics. However, interventions to improve medication use for chronic conditions appeared less effective overall and were often multifaceted, making it more difficult to synthesize published evaluations. 12 In this article, we extend the findings of the Cochrane review by providing a more detailed examination of interventions to improve adherence in chronic medical conditions. We offer a framework for categorizing these interventions and report their relative impact using a standardized measure of effect size (ES). The goal of this review is to help physicians better understand the strengths and limitations of tested interventions for improving long-term medication use and identify those that are most successful.
METHODS

DATA SOURCES
Electronic searches of the published literature from January 1967 to September 2004 were conducted through MEDLINE, CINAHL, PsycINFO, SOCIOFILE, International Pharmaceutical Abstracts, EMBASE, and The Cochrane Library, without language restriction. The exact search strategy varied across databases and generally included terms for adherence (eg, compliance, noncompliance, adherence, dropouts, treatment refusal), medication use (eg, medication, medicine, drug, treatment, regimen, pharmacotherapy), and clinical trial design (eg, clinical trial, intervention, outcome, randomized, control). A full description of the search strategy is provided elsewhere.
12
STUDY SELECTION
Reviewers screened citation titles, index terms, and abstracts (if available) to identify potentially relevant articles, which were retrieved for full-text review. Two reviewers independently assessed the articles for possible inclusion. Differences in assessment were resolved by discussion or with assistance from a third reviewer.
Articles were selected if they reported a randomized controlled trial that described 1 or more unconfounded interventions intended to enhance adherence with self-administered medications used in the treatment of chronic medical conditions. Confounding was judged to be present if study groups were treated unequally except for the intervention intended to enhance adherence (eg, patients in the intervention group received not only more encouragement to comply but also a different medication or dose than those in the control group). Included studies were required to report at least 1 measure of medication adherence and 1 clinical outcome, with at least 80% follow-up of participants during 6 months if the study results were initially positive. Studies with negative results and less than 6 months of follow-up were included because initial failure was unlikely to be followed by success. Studies of shortterm regimens were included in the Cochrane review 12 but excluded from the present analysis to permit a focus on chronic medical conditions, for which adherence is a greater concern. Trials that pertained to psychiatric disorders were excluded because adherence is generally lower in patients with psychiatric disorders and unique challenges may also be present, potentially limiting the generalizability of interventions tested in that context. 13 
DATA EXTRACTION
For each eligible study, 1 reviewer extracted features of the patient population, study design, interventions, and control, as well as results for adherence and clinical outcomes. When multiple time points were provided, data were extracted for the longest period of followup, provided follow-up remained at least 80%. Each extraction was confirmed by at least 1 other reviewer. Other articles on the same trial were retrieved, and authors were contacted as needed for additional details or verification of reported analyses.
DATA SYNTHESIS
The eligible studies differed substantially in patient population, intervention, adherence measure, and clinical outcome measure, making a pooling of results inappropriate.Instead,studiesweregrouped by intervention type, using a taxonomy developed from other sources. 8, 9, 14, 15 Informational interventions described cognitive strategies designed primarily to educate and motivate patients by instructional means, based on the concept that patients who understand their condition and its treatment will be more informed, empowered, and likely to comply. Informational sessions conducted individually or in a group setting, as well as didactic and interactive approaches, were included. Examples of informational interventions are face-to-face oral, telephone, written, or audiovisual education; didactic group class; and mailed instructional material (not including reminders or prompts to comply). Behavioral interventions were strategies designed to influence behavior through shaping, reminding (cues), or rewarding desired behavior (reinforcement). Examples include skill building by a health care professional; pillboxes, calendars, a change in packaging, or other steps intended to remind the patient; changes in dosage schedule to simplify the regimen or tailor the regimen to the patient's daily routine (ie, reduce its behavioral demands); and rewards and reinforcement (eg, assessment of adherence with feedback to the patient). Family and social interventions involved social support strategies, whether provided by family or another group. Examples are support groups and family counseling. Group sessions that were primarily didactic or informational, rather than supportive, were categorized as informational. Combined interventions included features of 2 or 3 of the preceding categories. Each included study was classified by 1 author using these categories, descriptors, and examples. This classification was reviewed by at least 1 other author, and disagreements were resolved by consensus.
For each outcome, an ES (Cohen d) with 95% confidence interval was calculated from information provided in the article or obtained from the authors. The ESs compare the difference in effect between study groups, divided by the standard deviation of this difference, resulting in standard deviation units. 16 This measure is independent of the method of measurement used, thus permitting comparison of different interventions across studies. In this way, ES provides more information than a simple test of significance comparing outcomes in intervention and control groups. The ES can be positive or negative, depending on the effect of the treatment on the particular outcome measure. If the study results are statistically significant, then the ES is generally significant as well.
We calculated ESs according to established methods. 16, 17 For studies that provided range instead of a standard deviation, we converted range to standard deviation. 18 The absolute value of each statistically significant ES was categorized as very small (Ͻ0.20), small (0.20 to Ͻ0.50), medium (0.50 to Ͻ0.80), or large (Ն0.80). 16 We calculated ESs between each intervention and control group. Some studies had more than 2 arms and provided only an overall test of significance comparing results across experimental groups. In these cases, the significance of the ES for intervention-control pairs may have differed from the overall significance of results. Also, if study authors did not specify the number of patients involved in the final analysis, we used the baseline sample size of each group to calculate the ES. Calculating the ES in this way, analogous to an intention-to-treat analysis, may underestimate the true effect of the intervention.
RESULTS
The electronic searches returned 13 061 citations (including 458 review articles), 955 of which were judged to merit full-text review. A total of 38 articles describing 37 randomized controlled trials met all inclusion criteria, including 2 articles from the same trial. 19, 20 Figure) .
Most studies reported a single measure of adherence. However, the choice of measure varied widely, from self-report scales to more objective measures obtained by auditing refill rates, performing pill counts, and assessing the timing of prescription bottle opening by Medication Event Monitoring System caps. Approximately half of the studies reported a single clinical outcome, which also varied greatly, depending on the patient population.
The ES could be calculated in 30 studies for adherence outcomes and in 30 studies for clinical outcomes. Most studies (71% for adherence and 100% for clinical outcomes) that did not provide enough information to calculate the ES were not statistically significant, which illustrated a form of reporting bias.
INFORMATIONAL INTERVENTIONS
The studies of informational interventions each compared intensive education to limited education or usual care ( Table 1) . Sample size varied from 46 to 350. The interventions ranged in duration from a single session of less than 1 hour to several hours over many sessions. Counseling was provided by a physician, nurse, health educator, or pharmacist. Both individual and group sessions were described, sometimes in combination, and they were often accompanied by written materials.
Half (6 of 12) of these studies reported a significant increase in at least 1 measure of adherence. [19] [20] [21] 23, 25, 28, 30 However, 3 of these 6 trials had mixed results. Gallefoss 19, 20 : ES, 0.52 for forced expiratory volume in 1 second in patients with asthma; Cote et al 22 : ES, −0.64 for urgent asthma-related visits and 3.41 for peak expiratory flow). Each of these 4 studies provided fairly intensive counseling with reinforcement over time. Only the interventions used by Cote et al 22 and Pradier et al 28 consistently led to better clinical outcomes, despite the study by Cote et al having no effect on adherence owing to a high rate of adherence in the control group (97%). Gallefoss et al 19, 20 again saw improvement only among the asthma subgroup, and Levy et al 25 had mixed results based on the clinical outcome measure.
BEHAVIORAL INTERVENTIONS
The sample size of the behavioral studies ranged from 27 to 497 ( Table 2 ). The most common and effective forms of behavioral intervention were dosage simplification 32, 34, 36 and repeated assessment of medication use with feedback. 35, [37] [38] [39] Other trials tested specialized packaging, 33 directly observed therapy, 40 and cognitive behavior therapy, 41 but none of these techniques significantly affected adherence or clinical outcomes.
All 3 trials of dosage simplification demonstrated an improvement in adherence, whether switching from 2 doses to 1 dose per day or from 4 to 2. 32, 34, 36 The ESs that could be calculatedwerelarge(range,0.89-1.20). 34, 36 The impact on clinical outcomes was mixed. Brown et al 34 found a significantly higher percentage of patients reached their low-density lipoprotein cholesterol goal when prescribed extended-release niacin compared with the short-acting form (medium ES of 0.66). However, the study by Baird significant improvement in blood pressure, whereas Girvin et al 36 actually found a trend toward increased blood pressure in the oncedaily therapy group.
The 4 trials that involved assessment and feedback asked patients to monitor and report their medication use and/or blood pressure. 35, [37] [38] [39] The 3 studies that then provided patients with tailored feedback, reinforcement, or rewards demonstrated a significant improvement in adherence (ESs small to large; range, 0.27-0.81). 35, 37, 39 The fourth study, which simply made home blood pressure values available to the patient and physician, did not improve adherence. 38 Only 1 study in this group produced a clear improvement in clinical outcomes (Marquez Contreras et al 39 : ES, 0.89 for total cholesterol and 0.78 for lowdensity lipoprotein cholesterol). Friedman and colleagues 35 reported a decrease in the diastolic blood pressure only after controlling for baseline blood pressure in adjusted analyses (small ES of 0.29); they found no significant change for systolic blood pressure.
COMBINED INTERVENTIONS
Most (13 of 15) combined interventions included informational and behavioral components, [42] [43] [44] [45] [47] [48] [49] [50] [51] [52] [53] [54] [55] and 2 joined social support strategies with either informational or behavioral elements (Table 3) . 46, 56 Sample size again varied widely, from 37 to 1113. Of the 13 studies with informational Abbreviations: C, control; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DMPA, depot-medroxyprogesterone acetate; ES, effect size; FEV 1 , forced expiratory volume in 1 second; FVC, forced vital capacity; HIV, human immunodeficiency virus; I, intervention; INR, international normalized ratio; MEMS, medication event monitoring system; NA, not available; NS, not significant; PEF, peak expiratory flow; PRECEDE, Predisposing, Reinforcing, Enabling, Causes in, Educational Diagnosis and Evaluation; ⌬, difference between intervention and control groups.
*Exact values not provided in article. Results are estimated from a figure. †Results obtained or confirmed by personal communication with authors. ‡Could not be calculated with available data. §The ES was calculated by converting range into standard deviation. ||The ES was calculated by using median instead of mean.
¶The 95% CI may be inaccurate owing to small sample size. #Lower score indicates better asthma control. Abbreviations: BP, blood pressure; C, control; CI, confidence interval; DBP, diastolic blood pressure; ES, effect size; HIV, human immunodeficiency virus; I, intervention; LDL-C, low-density lipoprotein cholesterol; MEMS, medication event monitoring system; NA, not available; NS, not significant; SBP, systolic blood pressure; ⌬, difference between intervention and control groups.
*Could not be calculated with available data. †Adjusted for age, sex, baseline BP, and baseline adherence; unadjusted analyses showed no significant difference. ‡Night-time SBP and DBP also showed a trend toward higher values in the intervention group. §Nonadherence was defined as failing to collect medications for 2 consecutive months. ||Adherence also compared by a 10-point visual analog scale, I = 9.93, C = 9.80, ⌬ = 0.13, P = .012.
¶The ES was calculated by using median instead of mean and by converting range to standard deviation.
and behavioral elements, 5 demonstrated improvement in all adherence measures, 42, 47, 48, 50, 51 
COMMENT
In this systematic review of randomized controlled trials designed to enhance medication adherence in chronic medical conditions, 16 of 37 trials reported a consistent improvement in adherence.* Four other studies noted a significant change in adherence among a particular patient subgroup, with some but not all of the adherence measures used, or in a certain arm of a study testing multiple interventions. 19, 20, 25, 30, 43 Nine of the 20 trials that had some impact on adherence were able to demonstrate an improvement in some 19, 20, 25, 35, 42, 48, 51 or all 28,34,39 of the measured clinical outcomes. Of the 17 studies that did not show an improvement in adherence, 2 improved clinical outcomes; the apparent lack of effect on adherence in these studies was probably due to insensitive adherence measures or a ceiling effect. 22, 55 Previous reviews have found few if any consistent relationships between the characteristics and effectiveness of interventions to improve adherence. 7 In the present study, categorization of the trials by intervention type (informational, behavioral, or combined informational, behavioral, and/or social support) and calculation of ESs permit a few general observations. Behavioral interventions that reduced the dosing demands of individual therapies consistently improved adherence with a large ES (0.89-1.20) . Apart from this, other successful interventions usually contained multiple elements delivered over time. For example, 6 informational interventions that provided educational counseling over a few sessions and addressed self-care issues improved adherence with small to large ESs (0.35-1.13). Successful behavioral interventions based in monitoring and feedback and the most successful combined interventions also included various elements, such as self-management plans, reinforcement, and occasionally rewards.
Despite the ability of these interventions to improve adherence, however, a positive effect on clinical outcomes was demonstrated infrequently, and ESs pertaining to clinical outcomes were highly variable (very small to large ES [0.17-3.41]). Moreover, results for clinical outcomes were not consistently related to the magnitude of adherence results or the characteristics of the intervention. Unfortunately, many of the studies were relatively small and not sufficiently powered to detect differences in clinical outcomes. Thus, the results of many of the studies are indeterminate for clinical outcome, rather than clearly negative.
The adherence literature and present study had several additional limitations. First, because we included only published trials, the reported findings may overestimate the true effect of such interventions due to publication bias. Second, our inclusion criteria were somewhat stringent. Many studies with shorter follow-up or no measurement of clinical outcomes were excluded, and they are listed elsewhere. 12 Third, our ability to categorize the trials into distinct modes of intervention was limited by the frequently complex nature of the interventions, requiring us to make judgments about the predominant components. Fourth, although we calculated ES and can make general comments about the magnitude of adherence and clinical outcome differences, the included studies were too heterogeneous to warrant pooling in a formal metaanalysis. Fifth, the literature review was completed in September 2004 and trials published since then may differ in their results, although they would be unlikely to substantially change the conclusions drawn from the 37 trials included in this review.
Because most of the available literature does not separate out the effects of the individual components of multifaceted interventions, it is not possible to draw definitive conclusions about which features of combined interventions are most beneficial. Additional research is needed to clarify which features are most responsible for changes in adherence and clinical outcomes, with the caveat that individual components may not prove powerful enough to show important effects. Future studies should also examine the effect of varying the intensity of interventions to determine doseresponse relationships. Such findings would have important implications for health systems considering the implementation of patient adherence programs on a large scale. Investigations should be conducted with clinically meaningful outcomes as the primary end points and be sufficiently powered to detect a difference in these measures. Most important, future research should seek to understand the determinants of adherence behavior and to develop and test innovative ways to help people adhere to prescribed medication regimens, rather than persisting with existing approaches.
In summary, we found that several types of interventions are effective in improving medication adherence, but few were able to demonstrate an impact on clinical * References 21, 23, 28, 32, [34] [35] [36] [37] 39, 42, [46] [47] [48] 50, 51, 56 . Abbreviations: C, control; CI, confidence interval; COPD, chronic obstructive pulmonary disease; DBP, diastolic blood pressure; ES, effect size; HbA 1c , hemoglobin A 1c ; HIV, human immunodeficiency virus; HRQOL, health-related quality of life; I, intervention; NA, not available; NS, not significant; PEF, peak expiratory flow; SF-36, 36-Item Short-Form Health Survey; ⌬, difference between intervention and control groups.
*Could not be calculated with available data. †P value recalculated from results in article. ‡Lower score indicates better adherence. §Intervention group had more urgent visits than control groups. ||Results obtained or confirmed by personal communication with authors. ¶Higher score indicates better adherence.
